Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection

NCT03728426 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infections

Interventions

DRUG: Letermovir

Sponsor

Amy C. Sherman, MD

Collaborators

[object Object]